Remala Abadi Tbk. vs Ikapharmindo Putramas Tbk. — how do they compare? Remala Abadi Tbk. trades at Rp2,450 (market cap 3.29T, 15.47M 24h volume), while Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 304.92B, 13.7K 24h volume). The key difference: Remala Abadi Tbk. is far larger — about 10.8× Ikapharmindo Putramas Tbk.'s market cap, and Remala Abadi Tbk. is more actively traded (15.47M versus 13.7K). Which is the better fit depends on your goals.
| DATA | IKPM | |
|---|---|---|
Market Cap | 3.29T | 304.92B |
Volume | 15.47M | 13.7K |
Lot | 154.74K | 137 |
Turnover | 37.99B | 2.49M |
Average Price | 2,454.89 | 181.39 |
Value | 37.99B | 2.49M |
Indicative Equilibrium Price | 2,450 | — |
Indicative Equilibrium Volume | 2.17K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT. Remala Abadi Tbk (the Company) was established based on Deed No.5, dated March 15, 2004 made before Notary Fajra Rizqi Nasution, SH. The company started its commercial activities since 2004.
Read more on DATA →PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →